ID
45165
Descrição
Principal Investigator: Andrzej Krolewski, MD, PhD, Joslin Diabetes Center, Boston, MA, USA MeSH: Diabetic Nephropathies https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000302 A collection of patients with type-2 diabetes was collected at the Joslin Diabetes Center. Patients were categorized to a group of cases with diabetic nephropathy, and a group of controls with normoalbuminuria. From these groups, 173 cases and 177 controls were randomly selected for a genome-wide association study.
Link
Palavras-chave
Versões (2)
- 25/08/2022 25/08/2022 - Chiara Middel
- 12/10/2022 12/10/2022 - Adrian Schulz
Titular dos direitos
Andrzej Krolewski, MD, PhD, Joslin Diabetes Center, Boston, MA, USA
Transferido a
12 de outubro de 2022
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
dbGaP phs000302 Genetic Study on Nephropathy in Type-2 Diabetes
Subject - Consent Information
- StudyEvent: SEV1
- Eligibility Criteria
- Subject - Consent Information
- Subject - Sample Mapping
- The dataset contains general diabetes 2 phenotype information including participants' case/control status (case: ESRD or proteinuria or microalbuminuria and chronic kidney disease [CKD] stage 4 or 5; control: normoalbuminuria, CKD Stage 1 or 2, at least 3 years duration and HbA1c of at least 6%), hemoglobin A1c values at study begin, BMI values, age of diabetes onset and duration etc., and general demographic information.
Similar models
Subject - Consent Information
- StudyEvent: SEV1
- Eligibility Criteria
- Subject - Consent Information
- Subject - Sample Mapping
- The dataset contains general diabetes 2 phenotype information including participants' case/control status (case: ESRD or proteinuria or microalbuminuria and chronic kidney disease [CKD] stage 4 or 5; control: normoalbuminuria, CKD Stage 1 or 2, at least 3 years duration and HbA1c of at least 6%), hemoglobin A1c values at study begin, BMI values, age of diabetes onset and duration etc., and general demographic information.